Question 1

What is the catalog number for 7,8-Dihydroxy-2,3,4,5-tetrahydro-2-benzazepine, Hydrobromide?

Accepted Answer

The catalog number for 7,8-Dihydroxy-2,3,4,5-tetrahydro-2-benzazepine, Hydrobromide is sc-217472.

Question 2

What sizes are available for 7,8-Dihydroxy-2,3,4,5-tetrahydro-2-benzazepine, Hydrobromide?

Accepted Answer

7,8-Dihydroxy-2,3,4,5-tetrahydro-2-benzazepine, Hydrobromide is available in the following size(s): 10 mg.

Question 3

Is 7,8-Dihydroxy-2,3,4,5-tetrahydro-2-benzazepine, Hydrobromide in stock?

Accepted Answer

7,8-Dihydroxy-2,3,4,5-tetrahydro-2-benzazepine, Hydrobromide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 5

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Question 6

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

7,8-Dihydroxy-2,3,4,5-tetrahydro-2-benzazepine, Hydrobromide

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Mucin 5AC (MUC5AC) (58M1), CF640R conjugate, 0.1mg/mL

CD3e (RIV9), CF594 conjugate, 0.1mg/mL

IgA Secretory Component (SC05), CF568 conjugate, 0.1mg/mL

Tenascin C (Stromal Marker For Epithelial Malignancy) (TNC/2981R), CF647 conjugate, 0.1mg/mL

Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1865R), CF568 conjugate, 0.1mg/mL

Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1993), CF488A conjugate, 0.1mg/mL